352 related articles for article (PubMed ID: 6132329)
1. Beta-blockers and the kidney.
Epstein M; Oster JR
Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
[No Abstract] [Full Text] [Related]
2. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
3. [Tertatolol--characteristics of the drug].
Tomaszewski R; Kliz J
Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
[No Abstract] [Full Text] [Related]
4. [Antihypertensive drugs and kidney function].
Belovezhdov N
Vutr Boles; 1990; 29(6):1-7. PubMed ID: 1982594
[No Abstract] [Full Text] [Related]
5. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
[TBL] [Abstract][Full Text] [Related]
6. The kidney and strategies for the treatment of hypertension.
Hollenberg NK
Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
[TBL] [Abstract][Full Text] [Related]
7. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
Danesh BJ; Brunton J; Sumner DJ
Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of beta-blockade hypotension.
Frohlich ED
N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
[No Abstract] [Full Text] [Related]
9. Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy.
Hollenberg NK
Medicographia; 1987; 9(3):2-4. PubMed ID: 11539067
[No Abstract] [Full Text] [Related]
10. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
[TBL] [Abstract][Full Text] [Related]
11. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
O'Connor DT; Barg AP; Duchin KL
J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol and the kidney.
Dupont AG
Clin Investig; 1992; 70 Suppl 1():S127-31. PubMed ID: 1350479
[TBL] [Abstract][Full Text] [Related]
13. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
Beaufils M
Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of beta-adrenoceptor antagonists on the kidney.
Waller DG; George CF
Adverse Drug React Acute Poisoning Rev; 1985; 4(1):1-21. PubMed ID: 2860792
[No Abstract] [Full Text] [Related]
15. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
17. Beta adrenoceptor blocking drugs in hypertension.
Turner P
Clin Invest Med; 1978; 1(3-4):129-33. PubMed ID: 42502
[No Abstract] [Full Text] [Related]
18. Redistribution of cardiac output to the kidneys during oral nadolol administration.
Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
[No Abstract] [Full Text] [Related]
19. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
Brunner H
Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
[No Abstract] [Full Text] [Related]
20. Effects of carvedilol on renal function.
Dupont AG
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
